Ocrelizumab Shows Promise for Primary Progressive MS
- Genentech’s Ocrelizumab First Investigational Medicine to Show Efficacy in People with Primary Progressive Multiple Sclerosis in Large Phase III Study. Genentech. Published September 27, 2015.
- Positive Results Announced from Phase III Clinical Trial of Ocrelizumab in Primary Progressive MS. National Multiple Sclerosis Society. Published September 28, 2015.
- Silva P. Could Genentech’s Ocrelizumab Become the First Effective Primary Progressive MS Therapy?. Multiple Sclerosis News Today. Published September 29, 2015.